Atea and Roche's COVID-19 antiviral flunks phase 2, prompting switch that will delay pivotal data

Atea and Roche's COVID-19 antiviral flunks phase 2, prompting switch that will delay pivotal data ntaylor Tue, 10/19/2021 - 08:11... Read more

Bron:

FierceBiotech